Table 1.
Patient characteristics
| Characteristic | Total (n=91) | SRT (n=57) | CRT (n=34) | p-value | |
|---|---|---|---|---|---|
| Median age (range, yr) | 64 (36-80) | 64 (39-81) | 65.5 (37-81) | ||
| Sex | Male | 86 (94.5) | 56 (98.2) | 30 (88.2) | 0.043 |
| Female | 5 (5.5) | 1 (1.8) | 4 (11.8) | ||
| Subsite | PS | 73 (80.2) | 48 (84.2) | 25 (73.5) | 0.401 |
| PW | 13 (14.3) | 6 (10.5) | 7 (20.6) | ||
| PC | 5 (5.5) | 3 (5.3) | 2 (5.9) | ||
| cT stage | cT1 | 8 (8.8) | 6 (10.5) | 2 (5.9) | 0.342 |
| cT2 | 26 (28.6) | 17 (29.8) | 9 (26.5) | ||
| cT3 | 27 (29.7) | 19 (33.3) | 8 (23.5) | ||
| cT4a | 30 (33.0) | 15 (26.3) | 15 (44.1) | ||
| cN stage | cN0 | 12 (13.2) | 6 (10.5) | 6 (17.6) | 0.618 |
| cN1 | 14 (15.4) | 8 (14.0) | 6 (17.6) | ||
| cN2 | 60 (65.9) | 39 (68.4) | 21 (61.8) | ||
| cN3 | 5 (5.5) | 4 (7.0) | 1 (2.9) | ||
| Stage | III | 17 (18.7) | 11 (19.3) | 6 (17.6) | 0.629 |
| IV a | 68 (74.7) | 42 (73.7) | 27 (79.4) | ||
| IV b | 6 (6.6) | 4 (7.0) | 1 (2.9) | ||
| RT | 3DCRT | 73 (80.2) | 51 (89.5) | 22 (64.7) | 0.004 |
| IMRT | 18 (19.8) | 6 (10.5) | 12 (35.3) |
Values are presented as number (%) unless otherwise indicated. SRT, surgery plus radiotherapy; CRT, chemoradiotherapy; PS, pyriform sinus; PW, pharyngeal wall; PC, postcricoid; cT, clinical T stage; 3DCRT, 3D conformal radiotherapy; IMRT, intensity-modulated radiotherapy.